Skip to main content

Advice for lay callers with low-risk poison exposures by a regional poison control center: the impact on health care expenditures

Abstract

Background

Since establishing the first poison control centers (PCCs), there is a still ongoing debate regarding their relevance and financing. The present study aims to analyze whether a regional PCC can reduce the economic burden associated with utilization of health care structures due to low-risk poison exposures on the German health care system.

Methods

A decision-tree based cost–benefit analysis comparing a situation utilizing PCC consultation versus a hypothetical situation without PCC consultation for low-risk poison exposures from the German health care system's perspective was conducted. The model inputs were obtained by a representative telephone survey of lay callers supplemented by empirical PCC and literature data. A probabilistic and deterministic sensitivity analysis with varying input variables was performed to prove the robustness of the findings.

Results

In the underlying telephone survey, data of 378 lay callers could be considered and included in the decision tree model. As a result, the mean costs for handling one low-risk poison exposure case were €41.99 utilizing PCC consultation compared to €145.92 without PCC consultation, indicating a cost–benefit ratio of 3.48 for the existence of the PCC. The sensitivity analysis proved that the outcome of the decision analysis does not change significantly with varying inputs.

Conclusion

The existence of PCCs relieve the burden on other health care providers and reduce health care costs to a relevant extent. Therefore, PCCs should be considered as an important supporting structure of the German health care system.

Peer Review reports

Introduction

The debate about inadequate public funding of poison control centers (PCCs) is almost as old as the facilities themselves. In the United States (US), the number of PCCs dropped from 661 to 55 (1978–2021) [1, 2] while in Germany only 7 [3] of the former 28 centers [4] still exist. The main reasons for reducing the number of PCCs were quality assurance reforms and insufficient public funding [5, 6]. Further reductions in the number of PCCs will likely affect the health care system, public budgets, and safety as their health and economic benefits have been shown: they can help to ensure a prompt and effective treatment [7], can save lives, help to reduce the unnecessary use of health care resources [8], lead to lower hospitalization rates [9] as well as reduced hospital length of stay [10, 11] and contribute to significant cost savings for the society [12,13,14,15,16,17,18]. Most of the studies regarding the economic benefits of PCCs are focused on the US health care system. The literature lacks support on how transferable these results are to the German or European context due to differences in the various countries' health care costs and health care structure. Studies from Europe are scarce, and for Germany only Bindl et al. [19] investigated the economic effects of a poison control center on health care costs in 1997. Deeper analysis and more recent data are needed for evidence-based decisions regarding the future funding of German PCCs. Therefore, this study aims to evaluate the cost–benefit ratio of a regional German PCC based on the current state of knowledge. We hypothesized that a scenario utilizing PCC consultation compared to a hypothetical scenario without PCC consultation would be associated with cost savings for the health care system, as unnecessary and more expensive health care contacts can be avoided.

Methods

Decision analysis

A decision tree model consistent with the simplified treatment pathways for exposures of laypersons (i.e., general public, no institutional callers) with poisoning concern was constructed (Fig. 1). The objective was to compare the costs of operating the PCC with its monetary benefit. For this, the perspective of the German health care system, including public health expenditures as well as the costs of private and statutory health insurance companies was taken. Analogous to comparable studies, the benefit was defined as the costs that can be avoided through the existence of the PCC. In the decision analysis, a situation utilizing PCC consultation and without PCC consultation was compared by calculating the average weighted financial outcome of each scenario. All input parameters used for the analysis can be found in the tables of Additional files 1 and 2. Calculations were performed using Microsoft Excel 2016 (Microsoft Corporation, Redmond, Washington, USA). The conducted analysis was based on the following assumptions:

  1. (1)

    All persons who call a medical doctor cause costs for medical advice. If the case is impossible to be solved by telephone, the medical doctor will send the affected person to the closest emergency department. Callers are not asked to come to the doctor's office for treatment.

  2. (2)

    If a layperson has already called the PCC, the attending medical doctor will not call the PCC again for this case.

  3. (3)

    Transition probabilities that could not be derived from the survey are assumed to be identical for the scenario with and without PCC consultation.

Fig. 1
figure 1

Decision tree with base case input values for low-risk poison exposures of laypersons in a situation utilizing PCC consultation and a hypothetical situation without PCC consultation. *Value derived from survey results; **Value derived from Berlin poison control center's data (2019); ED Emergency Department, EMS Emergency Medical Services, MD Medical Doctor

Determination of transition probabilities

The data for calculating transition probabilities were collected through a survey of former callers at the Berlin PCC (Charité, Berlin). The Berlin PCC is handling about 45,000 human poison exposure cases per year. About half of these inquiries are made by laypersons. Most lay inquiries concern children aged ≤ 12 years (approximately 78%). An age definition ≤ 12 years for children is also used by the "Einheitlicher Bewertungsmaßstab (EBM)", a nationwide catalog on which the reimbursement of services provided by “National Association of Statutory Health Insurance Physicians (NASHIP)” accredited doctors in Germany is based on. Since most lay calls involve low-risk poison exposures, home management (i.e., self-monitoring at home) can be recommended in approximately 90% of the cases. The remaining cases are moderate to severe poisonings that require urgent medical help.

Interview of Berlin poison control center's callers

Since the COVID-19 pandemic reached Germany in early 2020, there has been a distinct change in the use of public health facilities [20]. Due to this fact, only data from before the COVID-19 outbreak in Germany were used for the study. The sample was limited to calls between December 2019 and January 2020 to ensure that respondents would remember their last call to the Berlin PCC. For the survey, only calls from laypersons regarding poisoning exposures of humans were included in which management at home was recommended, as this group reflects most of the laypersons calling the PCC.

For ethical reasons, cases with suicidal or criminal intent were not considered. Consequently, 2,419 cases were potentially eligible for the survey. Using the “KNIME Analytics Platform 4.2.2” (KNIME AG, Zurich, Switzerland) [21] 1,500 cases were randomly selected. A standardized questionnaire for the telephone survey was designed by the authors, which was pretested with 30 persons for content and comprehensibility by one of the authors. The same person, who performed the pretest, conducted a retrospective telephone survey for a five-week period between November 9 and December 15, 2020 subsequently. The aim was to acquire a minimum of 377 survey respondents, including the 30 pretested persons, to obtain a sufficiently large sample size. The sample size was calculated based on a total population of 19,378 calls in 2019 that met the criteria described previously (confidence level: 95%, margin of error: 5%). All potential survey participants were called up to three times at different times of the day.

After explaining the purpose of the survey and obtaining informed consent, the participants were asked: 1) Which medical service/s he/she had used before or after calling the PCC, 2) What he/she would have done if the PCC had not been available, 3) Whether the affected person was covered by private or statutory health insurance at the time of the call.

If a survey participant could not answer one of the open questions, the possible response options were read to the interviewed person. All responses were recorded in a standardized manner so that a systematic evaluation was possible after completing the survey. All persons who did not consent or were unable to participate (e.g., could not remember the former PCC call) were excluded from the survey.

During the evaluation, the response options "Call physician," "Call hospital," and "Call 116,117Footnote 1" were merged in the main category "Call a medical doctor (MD)" to simplify the analysis. Moreover, the response options "Do research on the internet," "Call family/friends," "Do nothing/other," "Call a pharmacy," "Read the instructions on the packaging," and "I do not know" were combined in the main category "Do nothing/other" (Fig. 1 and Additional file 1).

Analysis of Berlin poison control center's data

Using the PCC's data (2019), the probabilities for the branches “Managed by MD/MD sends to ED”, “Outpatient treatment/Inpatient treatment” and “Managed by emergency service/Emergency service sends to ED” were determined, as they could not be obtained from the survey. To calculate the probabilities, the procedure recommended by the Berlin PCC for the different caller categories (doctors' office, hospital staff, and emergency services) were analyzed. Due to the fact that most lay inquiries have a low risk and concern children, only cases with asymptomatic patients aged ≤ 12 years were included to calculate transition probabilities (Fig. 1 and Additional file 1).

Determination of costs and charges

All costs and charges used in the analysis are stated in Euro.

The variable and fixed costs per case were taken into account to calculate the PPC's average cost for one lay consultation. Based on a mixed calculation, staff costs of €14.79 were determined to process and follow-up a layperson's inquiry. Overhead costs (e.g., administrative and IT staff, rate for space rental and utilities, technical equipment, office supplies) amount to €21.40. Overall, this results in total costs of €36.19 per case.

By using the EBM catalog, charges for the treatment of persons with statutory health insurance were identified. Costs for privately insured persons were considered by multiplying corresponding EBM charges by a factor of 2.28 [23]. According to our own empirical data, most requests address children. For that reason, charges for the treatment of children (≤ 12 years) rather than for adults were used whenever possible. To determine appropriate charges according to the EBM catalog a pediatrician, a general practitioner, and a head of an emergency department for children was interviewed. Except for the branches "Call MD → Managed by MD" and "Call MD → MD sends to ED," no surcharges were included for the use of medical services outside of consultation hours and on weekends. Moreover, only direct costs were considered and indirect costs were excluded (e.g., driving and waiting time, increased length of stay in the hospital, work loss days). Charges for the actions “Call 112 (EMS)Footnote 2” and “Call 112 (EMS) → Managed by emergency service/Emergency service sends to ED” were calculated based on data of the Berlin Fire Department [24]. The average costs for “Outpatient treatment” were derived from the literature [25], while the average costs for “Inpatient treatment” could be determined based on Charité controlling department data (2019). The actions “Management at home,” “Go to MD,” “Call MD,” “Go to hospital” and “Do nothing/other” were considered to be free of charge. Additional file 2 gives a detailed overview of all costs and charges included in the analysis.

Sensitivity analysis

A sensitivity analysis based on the input parameters presented in the tables of Additional files 1 and 2 was conducted to test the robustness of study results to changes in cost drivers and probabilities. For that, IBM SPSS Statistics 27 (IBM Corporation, Armonk, New York, USA) and Microsoft Excel 2016 (Microsoft Corporation, Redmond, Washington, USA) was used. For cost drivers, a variation of  ± 25% was assumed. Based on the survey results and PCC's data (2019), the minimum and maximum values (= upper and lower bound of 95% confidence interval) for the transition probabilities were calculated using the bias-corrected and accelerated (BCa) bootstrap method with 1,000 re-samples. A deterministic one-way sensitivity analysis (DSA) for each input parameter (base case and min./max. values) with consideration to the recommended procedure of Sendi and Clemen [26] for chance nodes with more than two branches was performed. To be able to take 0%-probabilities into account, a min./max. range of 0% to 1% was estimated for them in the DSA. In addition to the DSA, a probabilistic sensitivity analysis (PSA) was conducted using a Monte Carlo simulation with 1,000 iterations and a normal distribution assumption.

Results

From the randomly selected sample of 1,500 cases, 748 persons were contacted by telephone, of whom 310 could not be reached. Fifty persons were unable to answer (e.g., due to a lack of memory, false telephone number) and 10 persons did not gave their consent for participation. Finally, 378 persons participated fully in the survey. Figure 2 depicts the flow chart of survey participants. The participation rate of those reached by telephone was 86.3%.

Fig. 2
figure 2

Participant flow chart of the telephone survey

Of the survey participants, 27 (7.1%) reported having sought other medical help before contacting the PCC and 358 (94.7%) stated that they did not use other medical services after PCC consultation. Although only low-risk poison exposure cases with the recommended procedure "Management at home" were included in the survey, 20 individuals (5.3%) used further medical help after calling the PCC (Table 1).

Table 1 Actual used medical services before or after consulting the Berlin PCC and alternative actions of callers in a hypothetical scenario of PCC's absence

In a hypothetical scenario without PCC, the majority would have chosen the alternative "Call MD" (37.3%), or "Go to hospital" (32.8%), followed by "Call 112 (EMS)" (9.0%), "Go to MD" (8.5%), "Do nothing/other" (8.2%) and "Management at home" (4.2%) (Table 1). Regarding the type of insurance, 327 persons (86.5%) indicated that the affected person had statutory health insurance at the time of the call, 50 survey participants (13.2%) had private health insurance, and one person (0.3%) did not want to provide information on the type of insurance. The decision tree analysis (Fig. 1) resulted in average costs for treating low-risk poison exposures of €41.99 for the scenario utilizing PCC consultation and €145.92 in the absence of PCC consultation (base case scenario). Including the services used after consulting the PCC, the cost-saving amounts to €103.93 per case. The cost–benefit ratio for the base case is 3.48 (€145.92/€41.99). The deterministic one-way sensitivity analysis showed that the costs of “Inpatient treatment” and “Call PCC” as well as the probability of “Without PCC → Call 112 (EMS)” have the most noticeable influence on the calculated cost difference compared to the base case (Fig. 3).

Fig. 3
figure 3

Results of deterministic sensitivity analysis: effect of lower/upper input-values on saved costs per case compared to a situation without PCC [reference point are saved costs of €103.93 for the base case scenario]. ED Emergency Department, EMS Emergency Medical Services, MD Medical Doctor, PCC Poison Control Center

Overall, varying the input parameters by using the respective minimum and maximum values (Additional files 1 and 2) did not change the study findings to a relevant extent.

Figure 4 illustrates the results of the probabilistic sensitivity analysis. The histogram depicts the result of the Monte Carlo simulation. The figure shows the frequencies of saved costs per case subdivided by class. An average cost saving of €101.45 per case was calculated by means of the PSA. Analogous to the DSA, a situation utilizing PCC consultation leads to relevant cost savings in all cases. Both sensitivity analyses give strong support for the robustness of the study results.

Fig. 4
figure 4

Results of probabilistic sensitivity analysis: saved costs per case compared to a situation without PCC and frequencies under randomly and simultaneously varying input-values. PCC Poison Control Center

Discussion

The present study aimed to perform an in-depth cost–benefit analysis for a German PCC (Charité, Berlin) based on current data and wanted to investigate how a regional PCC helps to relieve the health care system as well as reduces costs for the treatment of low-risk poison exposures. During our study, a comprehensive decision tree model was created, that can be used as a framework for future research, resulting in more accurate results than previous studies. Our survey revealed that laypersons with suspected poisoning would consult a health care professional in 87.6% of the cases if a PCC would not be available. This proportion is consistent with the results of comparable studies by Descamps et al. [16] from Belgium and Toverud et al. [7] from Norway, which found percentages of 86.2% and 85.3%, respectively. Bindl et al. [19] determined in 1997 that 96% of callers would have sought other medical services in the absence of the PCC. In recent studies, the higher percentage of persons who would have looked for help elsewhere can be attributed to the increased use of the Internet and the improved networking among people. Overall, our findings provide evidence that PCCs absence would lead to increased use of regular medical services, putting more pressure on the already overburdened emergency services [27].

It gives cause for concern that 4.2% of the surveyed persons would have treated the affected person themselves in a scenario without PCC. It can be assumed that this could not only lead to incorrect care for poison exposure cases, but could also cause complications or long-term damages. Accordingly, PCCs contribute to minimize medical costs in acute poisoning cases and reduce subsequent expenses caused by no or inadequate treatment.

Regarding insurance status, it was found that 86.5% of the affected persons were covered by statutory health insurance and 13.2% by private insurance at the time of the PCC call. These proportions correspond to the national average of 87.8% and 10.5% [28].

Taking into account the characteristics of our survey group, we calculated a cost–benefit ratio of 3.48. In comparable studies from the US, values ranged from 2.03 to 36 [12]. For European PCCs cost–benefit ratios from 0.76 to 5.70 were reported [7, 16, 19, 29]. Within the European studies, our result is closest to Bindl et al. [19], who found a ratio between 1.38 and 2.17 (calculation by authors based on study data). The differences in results are mainly due to the studies' differing methodological approaches and the variation in estimated costs. As proven by our sensitivity analysis, the costs of inpatient treatment, costs per PCC call, and the probability of calling 112 (EMS) in a situation without PCC have the most relevant influence on the calculated ratio.

Limitations

A limitation of the study is that the modeled decision tree is a simplified representation of reality and only contains the most relevant elements for the cost–benefit analysis. Moreover, not all decision possibilities could be covered by empirical data. The option that the PCC is contacted multiple times for a specific case was not quantifiable and consequently could also not be considered. However, experience shows that medical professionals often call the PCC for cases on which laypersons already received advice. These additional calls of medical professionals can often avoid unnecessary emergency room visits and hospitalizations. Thus, it can be hypothesized that the calculated benefits of PCC would further increase if the study would take this fact also into account.

Our study only considered low-risk poison exposures from calling laypersons, leading to a one-sided view on the cost–benefit ratio of a PCC. Future work should therefore include moderate and severe poisoning cases, as well as calls from medical professionals in the cost–benefit analysis. The effect of a German PCC on outcomes such as hospital length of stay, patient mortality and morbidity, health-related quality of life and the number of poison exposures should additionally be investigated in further studies.

During the interview, it turned out that some persons had initially consulted other medical services before they were referred to the PCC. This circumstance could reduce the reported benefit. However, it can be assumed that prior use of other medical services could be nearly eliminated if awareness of PCC's emergency number would increase. For this reason, we have decided against the correction of the calculated benefit in this regard.

A further limitation of the study is that charges could not be transferred into costs. Consequently, costs and charges had to be mixed in the analysis.

Furthermore, only the direct costs from the health care system's perspective were used for calculating the benefit. Hence, the benefit estimates in the present study are rather conservative. A whole-society view incorporating indirect costs (e.g., waiting time, work loss days, perceived stress) and PCC's secondary benefits (e.g., through prevention work, toxicovigilance and health reporting) would lead to a more realistic cost–benefit ratio [30].

With regard to the study design, it is important to note that the time of day when a poisoning case occurs may influence the affected person's response and following treatment procedures. Therefore, the survey participants were selected randomly to minimize bias in the study results. An additional limitation of the study could result from a recall bias of the survey participants. To counteract this, all individuals who indicated that they could not accurately recall their contact with the PCC were excluded from the survey. Nevertheless, bias in the results likely occurred because parents often experience a suspected poisoning of their child as an acute emergency. Almost a year after knowing the child was treated at home, parents probably underestimate the alternative actions in a hypothetical situation without PCC [31].

Conclusion

This study shows that PCCs reduce the usage of existing, more expensive medical services and thus reduce health care costs to a relevant extent. According to this finding, PCCs should be considered as an important supporting structure of the German health care system.

Availability of data and materials

The datasets generated during the current study are available from the corresponding author on reasonable request.

Notes

  1. 116,117 is a nationwide telephone number for on-call outpatient medical services in Germany. The hotline connects local medical doctors with patients in urgent medical cases outside regular office hours (at night, on weekends, and public holidays) [22].

  2. 112 is the telephone number of emergency medical services (EMS) in Europe.

Abbreviations

BCa:

Bias-corrected and accelerated

DSA:

Deterministic Sensitivity Analysis

EBM:

Einheitlicher Bewertungsmaßstab

ED:

Emergency Department

EMS:

Emergency Medical Services

MD:

Medical Doctor

PCC:

Poison Conrol Center

PSA:

Probabilistic Sensitivity Analysis

References

  1. Scherz RG, Robertson WO. The history of poison control centers in the United States. Clin Toxicol. 1978;12(3):291–6. https://doi.org/10.3109/15563657809150481.

    Article  CAS  PubMed  Google Scholar 

  2. American Association of Poison Control Centers (AAPCC): About AAPCC. 2021. https://aapcc.org/about. Accessed 19 Mar 2021.

  3. Bundesinstitut für Risikobewertung (BfR): Verzeichnis der Giftinformationszentren der Bundesrepublik Deutschland (gemeldet nach § 16e ChemG). 2021. https://www.bfr.bund.de/cm/343/verzeichnis-der-giftinformationszentren-der-bundesrepublik-deutschland.pdf. Accessed 4 Oct 2021.

  4. Hahn A, Begemann K. Poison centres in Germany - history, function, and relevance. Bundesgesundheitsbl. 2019;62(11):1304–12. https://doi.org/10.1007/s00103-019-03023-8.

    Article  Google Scholar 

  5. Stiftung Warentest. Erste Hilfe bei Vergiftungen: Schneller als die Feuerwehr; 2002. https://www.test.de/Erste-Hilfe-bei-Vergiftungen-Schneller-als-die-Feuerwehr-1039653-2039653/. Accessed 16 Nov 2022.

  6. Tutdibi E. Jahresbericht 2019. Homburg/Saar: Informations- und Behandlungszentrum für Vergiftungen Homburg/Saar, Poison Control Center; 2020.

  7. Toverud EL, Pike E, Walloe L. The national poison center in Norway: user satisfaction and a health economic evaluation. Eur J Clin Pharmacol. 2009;65(9):935–40. https://doi.org/10.1007/s00228-009-0693-9.

    Article  PubMed  Google Scholar 

  8. Spiller HA, Singleton MD. Comparison of incidence of hospital utilization for poisoning and other injury types. Public Health Rep. 2011;126(1):94–9. https://doi.org/10.1177/003335491112600113.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Zaloshnja E, Miller T, Jones P, Litovitz T, Coben J, Steiner C, et al. The potential impact of poison control centers on rural hospitalization rates for poisoning. Pediatrics. 2006;118(5):2094–100. https://doi.org/10.1542/peds.2006-1585.

    Article  PubMed  Google Scholar 

  10. Galvao TF, Silva MT, Silva CD, Barotto AM, Gavioli IL, Bucaretchi F, et al. Impact of a poison control center on the length of hospital stay of poisoned patients: retrospective cohort. Sao Paulo Med J. 2011;129(1):23–9. https://doi.org/10.1590/s1516-31802011000100005.

    Article  PubMed  Google Scholar 

  11. Farkas A, Kostic M, Huang CC, Gummin D. Poison center consultation reduces hospital length of stay. Clin Toxicol (Phila). 2022;60(7):1–6. https://doi.org/10.1080/15563650.2022.2039686.

    Article  Google Scholar 

  12. Galvao TF, Silva EN, Silva MT, Bronstein AC, Pereira MG. Economic evaluation of poison centers: a systematic review. Int J Technol Assess Health Care. 2012;28(2):86–92. https://doi.org/10.1017/S0266462312000116.

    Article  PubMed  Google Scholar 

  13. The Lewin Group Inc. Final report on the value of the poison center system. Prepared for: American Association of Poison Control Centers (AAPCC); 2012. https://www.poison.org/-/media/files/webpoisoncontrol/press-info/lewin-report-value-of-the-poison-center-system.pdf. Accessed 16 Nov 2022.

  14. Ponampalam R, Loh CS. Cost benefits of the drug and poison information centre in preventing unnecessary hospitalisation: the Singapore experience. Hong Kong J Emerg Med. 2010;17(1):45–53. https://doi.org/10.1177/102490791001700108.

    Article  Google Scholar 

  15. Tak CR, Malheiro MC, Bennett HK, Crouch BI. The value of a poison control center in preventing unnecessary ED visits and hospital charges: a multi-year analysis. Am J Emerg Med. 2017;35(3):438–43. https://doi.org/10.1016/j.ajem.2016.11.049.

    Article  PubMed  Google Scholar 

  16. Descamps AK, De Paepe P, Buylaert WA, Mostin MA, Vandijck DM. Belgian poison centre impact on healthcare expenses of unintentional poisonings: a cost-benefit analysis. Int J Public Health. 2019;64(9):1283–90. https://doi.org/10.1007/s00038-019-01283-4.

    Article  PubMed  Google Scholar 

  17. Huynh A, Cairns R, Brown JA, Jan S, Robinson J, Lynch A-M, et al. Health care cost savings from Australian Poisons Information Centre advice for low risk exposure calls: SNAPSHOT 2. Clin Toxicol. 2020;58(7):752–7. https://doi.org/10.1080/15563650.2019.1686513.

    Article  Google Scholar 

  18. Nicholls E, Sullivan T, Zeng J, Pomerleau AC. Staying at home: the potential cost savings related to triage advice provided by the New Zealand National Poisons Centre. Clin Toxicol. 2021;60(1):1–7. https://doi.org/10.1080/15563650.2021.1937641.

    Article  Google Scholar 

  19. Bindl L, Ruchardt J, Pfeiffer A, Kowalewski S, Lentze MJ. Effect of a German poison control center on health care cost reductions in harmless exposure cases. Vet Hum Toxicol. 1997;39(1):48–50.

    CAS  PubMed  Google Scholar 

  20. Tschaikowsky T, Becker von Rose A, Consalvo S, Pfluger P, Barthel P, Spinner CD, et al. Numbers of emergency room patients during the COVID-19 pandemic. Notfall + Rettungsmedizin. 2020;24(6):1–10. https://doi.org/10.1007/s10049-020-00757-w.

  21. KNIME AG: KNIME Analytics Platform. https://www.knime.com/knime-analytics-platform (2020). Accessed 25 May 2020.

  22. Kassenärztliche Bundesvereinigung KdöR: Der ärztliche Bereitschaftsdienst. 2021. https://www.116117.de/de/aerztlicher-bereitschaftsdienst.php. Accessed 22 Mar 2021.

  23. Niehaus F. Ein Vergleich der ärztlichen Vergütung nach GOÄ und EBM, WIP-Diskussionspapier 7/09. Köln: Wissenschaftliches Institut der PKV (WIP); 2009. https://www.wip-pkv.de/fileadmin/DATEN/Dokumente/Veroeffentlichungen/Vergleich_der_aerztlichen_Verguetung_nach_GOAE_und_EBM.pdf. Accessed 16 Nov 2022.

  24. Land Berlin. Gebührenordnung für die Benutzung von Einrichtungen der Berliner Feuerwehr und die kostenersatzpflichtige Alarmierung/Inanspruchnahme von Einrichtungen der Berliner Feuerwehr (Feuerwehrbenutzungsgebührenordnung - Fw BenGebO -) in der Fassung vom 13. April 1995; 2021. https://gesetze.berlin.de/bsbe/document/jlr-FeuerwEBenGebOBEV11Anl-G1. Accessed 16 Nov 2022.

  25. Haas C, Larbig M, Schöpke T, Lübke-Naberhaus K-D, Schmidt C, Brachmann M, et al. Gutachten zur ambulanten Notfallversorgung im Krankenhaus: Fallkostenkalkulation und Strukturanalyse. Management Consult Kestermann GmbH (MCK) in cooperation with Deutsche Gesellschaft interdisziplinäre Notfall- und Akutmedizin e. V. (DGINA); 2015. https://www.dkgev.de/fileadmin/default/Mediapool/2_Themen/2.2_Finanzierung_und_Leistungskataloge/2.2.4._Ambulante_Verguetung/2.2.4.4._Ambulante_Notfallvehandlung_durch_Krankenhaeuser/2015-02-17_Gutachten_zur_ambulanten_Notfallversorgung_im_Krankenhaus_2015.pdf. Accessed 16 Nov 2022.

  26. Sendi PP, Clemen RT. Sensitivity analysis on a chance node with more than two branches. Med Decis Making. 1999;19(4):499–502. https://doi.org/10.1177/0272989X9901900418.

    Article  CAS  PubMed  Google Scholar 

  27. Arbeitsgruppe „Ambulante und stationäre Versorgung“. (Politische) Rahmenbedingungen einer sektorenübergreifenden Versorgung in Notfallpraxen und Notaufnahmen - Argumentationspapier. Berlin: Bundesärztekammer; 2017. https://www.bundesaerztekammer.de/fileadmin/user_upload/BAEK/Politik/Programme-Positionen/2017-05-09_Rahmenbedingungen_Versorgung_in_Notfallpraxen_und_Notaufnahmen-Anregungen_mit_Deckblatt.pdf. Accessed 16 Nov 2022.

  28. Verband der Ersatzkassen e. V. (vdek): Krankenversicherungsschutz der Bevölkerung: in Prozent und Millionen 2019. 2021. https://www.vdek.com/presse/daten/b_versicherte.html. Accessed 20 Apr 2021.

  29. Anell A, Persson M. Toxicologic information center’s hotline - well-received and cost-effective for the society. Lakartidningen. 2001;98(24):2926–30.

    CAS  PubMed  Google Scholar 

  30. Harrison DL, Draugalis JR, Slack MK, Tong TG. The production model as a basis for conducting economic evaluations of regional poison control centers. J Toxicol Clin Toxicol. 1995;33(3):233–7. https://doi.org/10.3109/15563659509017989.

    Article  CAS  PubMed  Google Scholar 

  31. Blizzard JC, Michels JE, Richardson WH, Reeder CE, Schulz RM, Holstege CP. Cost-benefit analysis of a regional poison center. Clin Toxicol (Phila). 2008;46(5):450–6. https://doi.org/10.1080/15563650701616145.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Open Access funding enabled and organized by Projekt DEAL. No funding was received for conducting this study.

Author information

Authors and Affiliations

Authors

Contributions

FT and TR conceived the study. FT conducted the survey and analyzed the data. The first draft of the manuscript was written by FT while TR provided critical revision of the article. Both authors read and approved the final manuscript.

Corresponding author

Correspondence to Franziska Thal.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the ethics committee of the Charité – Universitätsmedizin Berlin (EA2/219/21). Informed consent was obtained from each participant before the survey was conducted.

Consent for publication

Not applicable.

Competing interests

The authors have no conflicts of interest to declare that are relevant to the content of this article.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1. Supplementary Table S1.

Transition probabilities of the decision tree.

Additional file 2. Supplementary Table S2.

 Cost/charges per case of the decision tree.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thal, F., Reinhold, T. Advice for lay callers with low-risk poison exposures by a regional poison control center: the impact on health care expenditures. Arch Public Health 80, 243 (2022). https://doi.org/10.1186/s13690-022-00994-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13690-022-00994-0

Keywords